Anzeige
Mehr »
Login
Samstag, 05.10.2024 Börsentäglich über 12.000 News von 690 internationalen Medien
Citibank´s $3.000-Gold-Prognose und die $60-Millionen-Wette, die den Mining-Sektor neu definieren könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
577 Leser
Artikel bewerten:
(2)

Acron Group's Output Up 6% in 2021

19 January 2022

Acron Group's Output Up 6% in 2021

The Group's Consolidated Output

(including operating results for Acron, Dorogobuzh,

and North-Western Phosphorous Company)

Product, '000 t20212020YOY, %
MINERAL FERTILISERS
Ammonia2,9092,7296.6%
Incl. in-house consumption2,8452,617
Nitrogen fertilisers, including5,0584,7077.5%
Incl. in-house consumption921690
AN2,2412,430-7.8%
Incl. in-house consumption339213
Urea1,4631,18023.9%
Incl. in-house consumption582477
Incl. prilled urea400485-17.5%
Incl. in-house consumption1716
Incl. granulated urea529261102.7%
Incl. in-house consumption3226
UAN1,3541,09623.5%
Complex fertilisers, including2,6252,37210.7%
Incl. in-house consumption6152
NPK2,4062,2367.6%
Incl. in-house consumption6152
Bulk blends21913661.0%
Total commercial output for Mineral Fertilisers6,7656,4484.9%
INDUSTRIAL PRODUCTS
Organic compounds, including47442312.1%
Incl. in-house consumption246213
Methanol105987.7%
Incl. in-house consumption9178
Formalin16915112.4%
Incl. in-house consumption150131
Urea-formaldehyde resins19917414.3%
Incl. in-house consumption64
Non-organic compounds, including:1,1871,03514.6%
Low-density and technical-grade AN46931847.5%
Industrial urea17014022.1%
Calcium carbonate483515-6.3%
Liquid carbon dioxide57553.1%
Argon77-2.3%
Total commercial output for Industrial Products1,4151,24513.6%
RAW PHOSPHATES
Apatite concentrate1,2551,1826.1%
Incl. in-house consumption950900
Total commercial output for Apatite Concentrate3052837.9%
TOTAL COMMERCIAL OUTPUT8,4857,9766.4%

Note:

Commercial output is output less in-house consumption.

Chairman of Acron's Board of Directors Alexander Popov commented on the results:

'Acron Group set a new record in 2021, ramping up commercial output 6% year-on-year to 8.5 million tonnes and outstripping the target set a year ago. As a key milestone in 2021 we can name completed Urea-6+ project that brought urea output to record 1.6 million tonnes.

'Looking forward, we want to use the upward momentum of mineral fertiliser prices in 2021 and both accelerate ongoing investment projects and kick off new ones.

'Upgrades to ammonia units 2 and 3 and urea units 1 through 4 are underway at Acron's Novgorod-based site. We plan to complete these projects in 2023, which will boost ammonia capacity by 375 ktpa and urea capacity by 390 ktpa. At the same time, we will construct a second urea granulation unit.

'In 2022, we plan to complete construction of a 100-ktpa calcium nitrate unit. We are undertaking production of this new water-soluble fertiliser in response to client demand around the world.

'The Dorogobuzh site will see technical upgrades at its ammonia unit and the completion of a new nitric acid unit, which will result in a higher ammonium nitrate output and allow us to increase supplies to the domestic market, where this nitrogen fertiliser is traditionally popular.

'We expect the Group's commercial output to reach 8.7 million tonnes in 2022'.

Performance Analysis

In 2021, Acron Group's total commercial output was up 6% to 8,485,000 tonnes. This increase was mainly due to a number of investment projects implemented at the Group's Novgorod-based site in the recent years, including construction of a urea granulation unit in mid-2020, a capacity increase at the Ammonia-4 unit in late 2020, and a comprehensive overhaul of the Urea-6 unit in 2021. These efforts boosted output of nitrogen mineral fertilisers, industrial urea, and ammonium nitrate.

The Group's mineral fertiliser output was up 5% to 6,765,000 tonnes last year. Industrial product output increased 14% to 1,415,000 tonnes following the Group's success at promoting industrial-grade urea and ammonium nitrate in international markets. Output of these products was up 40% to 640,000 tonnes.

In 2021, the Group's ammonia output was up 7% to 2,909,000 tonnes, and the volume of ammonia processed through to end products increased to 98% from 96%.

As production of industrial-grade ammonium nitrate went up last year, the Group saw an 8% dip in output of agricultural-grade ammonium nitrate to 2,241,000 tonnes. Output of agricultural-grade urea, however, was up 24% to 1,463,000 tonnes. The Group launched production of granulated urea in 2020 and doubled its output in 2021 year-on-year to 529,000 tonnes. UAN output was up 24% year-on-year to 1,354,000 tonnes due to a better price environment.

The Group's output of complex fertilisers was up 11% in 2021 to 2,625,000 tonnes, backed by both a favourable price environment and increased production of apatite concentrate at the Oleniy Ruchey mine, where output was up 6% to 1,255,000 tonnes.

Market Trends

Global urea prices soared in Q4 2021. FOB Baltic Sea prices reached an all-time record high of USD 900 per tonne after a significant jump in natural gas prices with associated shutdowns of some capacity in Europe and export restrictions in China, Egypt, and Russia. Prices were further supported by strong demand from India and Brazil and high demand for urea in the industrial sector. In January 2022, urea prices adjusted as the import season came to a close in India and Brazil. That said, prices continue to be supported by high gas prices in Europe and export restrictions in China, Russia, and Egypt.

Like urea, ammonium nitrate and UAN prices increased rapidly in Q4 2021. FOB Baltic Sea prices set new records (USD 750 and USD 630 per tonne of AN and UAN respectively) backed by higher urea prices, which serve as a benchmark for these fertilisers, and higher production costs for these products in Europe resulting from soaring gas prices. Despite these issues, Russian producers continue to meet their commitments to support the domestic market and supply fertilisers to Russian growers at prices far below the global market.

NPK prices were on the rise in Q4 2021, driven mainly by higher prices for the basic products (urea, DAP, and potassium chloride). The increase in basic product prices outstripped blends because of their higher liquidity, so NPK 16-16-16 sold at a 5% discount to the basic product basket despite its historical average premium of about 20%. The premium over the basic products is expected to return to normal in the coming months.

Average Indicative Prices, USD/t, FOB Baltic/Black Sea

Q4 2021Q3 2021Q4 2020Q4 2021 /
Q3 2021

change
Q4 2021 /
Q4 2020

change
NPK 16-16-1657942526236.2%121.0%
AN646309166109.1%289.2%
UAN61230811998.7%414.3%
Urea80744523481.3%244.9%
Ammonia82257121144.0%289.6%

202120202021/2020
NPK 16-16-1641625662.5%
AN355167112.6%
UAN356125184.8%
Urea480222116.2%
Ammonia543204166.2%

Media contacts:

Sergey Dorofeev

Anastasia Gromova

Tatiana Smirnova

Public Relations

Phone: +7 (495) 777-08-65 (ext. 5196)

Investor contacts:

Ilya Popov

Investor Relations

Phone: +7 (495) 745-77-45 (ext. 5252)

Background Information

Acron Group is a leading vertically integrated mineral fertiliser producer in Russia and globally, with chemical production facilities in Veliky Novgorod (Acron) and Smolensk region (Dorogobuzh). The Group owns and operates a phosphate mine in Murmansk region (North-Western Phosphorous Company, NWPC) and is implementing a potash development project in Perm Krai (Verkhnekamsk Potash Company, VPC). It owns transportation and logistics infrastructure, including three Baltic seaport terminals and distribution networks in Russia and China. Acron subsidiary North Atlantic Potash Inc. (NAP) holds mining leases and an exploration permit for ten parcels of the potassium salt deposit at Prairie Evaporite, Saskatchewan, Canada. Acron also holds a minority stake (19.8%) in Polish Grupa Azoty S.A., one of the largest chemical producers in Europe.

In 2020, the Group sold 7.8 million tonnes of its main products to 74 countries, with Russia, Brazil, Europe, and the United States as key markets.

In 2020, the Group posted consolidated IFRS revenue of RUB 119,864 million (USD 1,661 million), with EBITDA of RUB 35,311 million (USD 489 million). Acron's shares are traded on the Moscow Exchange, and its global depositary receipts are traded at the London Stock Exchange (ticker AKRN). Acron employs over 11,000 people.r

For more information about Acron Group, please visit www.acron.ru/en.


© 2022 GlobeNewswire (Europe)
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.